Yakira Capital Management’s CB PHARMA ACQUISISTION CORP SHS (CYM) CNLM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-12,500
Closed -$126K 112
2016
Q1
$126K Hold
12,500
0.04% 98
2015
Q4
$124K Hold
12,500
0.03% 103
2015
Q3
$124K Hold
12,500
0.07% 106
2015
Q2
$124K Buy
+12,500
New +$123K 0.07% 105

Yakira Capital Management's CNLM Position: Q2 2016 in Review

Yakira Capital Management sold out of CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) in Q2 2016, closing a stake of 12,500 shares — an estimated $126K sold.

Yakira Capital Management first reported a position in CNLM in Q2 2015 and held it in 4 quarters. The position peaked at $126K in Q1 2016. 0 funds tracked by Wall St. Rank hold CNLM as of Q2 2016.

  • Yakira Capital Management reported no remaining CB PHARMA ACQUISISTION CORP SHS (CYM) position as of Q2 2016 after selling out during the quarter.
  • Yakira Capital Management sold 12,500 CB PHARMA ACQUISISTION CORP SHS (CYM) shares in Q2 2016, an estimated $126K.
  • Yakira Capital Management first reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) in Q2 2015 and held it in 4 quarters.
  • Yakira Capital Management's CB PHARMA ACQUISISTION CORP SHS (CYM) position peaked at $126K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held CB PHARMA ACQUISISTION CORP SHS (CYM) as of Q2 2016.

Based on Yakira Capital Management's 13F filing for Q2 2016, filed 11 Aug 2016.